TrialHaemophilia : the official journal of the World Federation of Hemophilia2019

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data.

Hermann Eichler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.